Overview

Compassionate Use of Omegaven IV Fat Emulsion

Status:
No longer available
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This protocol involves the compassionate use of intravenous fish oil infusion, Omegaven. The protocol involves infants and children with parenteral nutrition-associated liver disease to enable the reversal of elevated serum liver enzymes and direct bilirubin (cholestasis).
Details
Lead Sponsor:
Northwell Health